Product logins

Find logins to all Clarivate products below.


Physician-Dispensed Cosmeceuticals | Market Insights | Europe | 2024

The European physician-dispensed cosmeceutical market will expand strongly over the forecast period. Growth in the physician-dispensed cosmeceutical market will be driven by the high patient demand for aesthetic procedures, which is fueled by a strong aesthetic consciousness in Europe and online availability of physician-dispensed cosmeceuticals, although growth will be limited by the increasing availability of alternative, online retail channels for professional quality products.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for physician-dispensed cosmeceuticals in Europe from 2019 through 2032.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…
Report
Cardiac Assist Devices – Market Insights – Europe
The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient…